A stereotactic breast biopsy is a procedure that takes a tissue sample from a suspicious area in the breast. Your healthcare ...

Patients with early breast cancer who skipped axillary lymph node dissection (ALND) lived just as long as those who underwent ...

Results of the INSEMA trial indicated that it’s safe to omit axillary sentinel lymph node biopsy in patients with clinically ...

In addition, rise in funding for breast liquid biopsy R&D, favorable initiatives undertaken by governments and global health organizations, and increase in breast cancer liquid biopsy reagents ...

Dr. Marla Lipsyc-Sharf reviews her recent session at the 2024 SABCS meeting, discussing biopsy approaches and treatment ...

Omitting axillary SLNB does not impact outcomes in patients with early invasive breast cancer undergoing breast-conserving surgery, data suggest.

BioMark Expands Its Liquid Biopsy Platform Receptor Status for Breast Cancer Vancouver, British Columbia--( - December 10, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ...

PanGIA Biotech–a pioneer in liquid biopsy technology–today announced its first international partnership, collaborating with Canary Oncoceutics (Canar ...

The team showed that it could use routinely collected biopsy images to predict genetic variations in breast cancers and to predict patient outcomes. This kind of software could be used to quickly ...

BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a leader in liquid biopsy tests for early cancer detection ...